Scalpel Weekly News

Week of: September 12, 2016

IN THE NEWS


Clot Retrieval Devices Approved for Use with t-PA for Early Stroke Treatment

On September 2, 2016, the FDA permitted marketing of two Trevo clot retrieval devices as an initial therapy for strokes due to blood clots (ischemic) to reduce paralysis, speech difficulties, and other stroke disabilities. These devices should be used within six hours of symptom onset and only following treatment with a clot-dissolving drug (tissue plasminogen activator or t-PA), which needs to be given within three hours of symptom onset. Click title to continue reading...


 
MEDICAL ALERTS


FDA Strengthens Warnings for Combined Use of Opioids and Antidepressants

After an extensive review of the latest scientific evidence, the FDA announced on August 31, 2016, that it is requiring class-wide changes to drug labeling, including patient information, to help inform health care providers and patients of the serious risks associated with the combined use of certain opioid medications and a class of central nervous system (CNS) depressant drugs called benzodiazepines. Click title to continue reading... 



Reports of Bleeding with Patch Used for Surgery to Reduce Risk of Stroke

On September 1, 2016, the FDA announced that it has recently received multiple adverse event reports associated with Baxter International Inc.’s Vascu-Guard Peripheral Vascular Patch (also referred to as the Vascu-Guard patch) during carotid endarterectomy (CEA). CEA is a surgical procedure used to reduce the risk of stroke, by correcting stenosis (narrowing) in the common carotid artery or internal carotid artery by removing material from the inside of the carotid artery. Click title to continue reading...



Molecular Technologies Help Detect and Interrupt Superbug CRE Transmission

On September 2, 2016, the CDC published a report on the use of molecular technologies to detect and interrupt Carbapenem-resistant Enterobacteriaceae (CRE) transmission. CRE are multidrug-resistant gram-negative bacilli that can cause infections associated with high case fatality rates, and are emerging as epidemiologically important health care–associated pathogens in the United States. Prevention of CRE transmission in health care settings is dependent on recognition of cases, isolation of colonized and infected patients, effective use of infection control measures, and the correct use of antibiotics. Click title to continue reading...


  CASE ALERTS


Massachusetts Adopts Continuing Treatment Doctrine; Inapplicable to Treatment Team

A boy was born with a lump in his right leg. Within a few weeks of his birth, his family was referred to the sarcoma group at a hospital. The sarcoma group is a multidisciplinary group that included a variety of practitioners. The group met weekly to discuss new cases and old cases that needed to be revisited. The group made decisions together and developed treatment plans together. The boy was cared for by the sarcoma group for many years. Click title to continue reading...



Latex Allergy Claim Barred; No Intent for Immediate Service of Complaint

A woman with a latex allergy underwent surgery. She suffered from a severe allergic reaction. One day shy of two years after she underwent surgery, the woman filed a complaint in the Montgomery Circuit Court against the surgeon, his practice group, and the surgical facility for medical malpractice. Click title to continue reading...



Contract without Judgment or Settlement Meets MSP Act’s “Demonstrated Responsibility”

Automobile owners and operators in Florida covered by personal injury protection (PIP) no-fault insurance were injured in automobile accidents. Each insured was also enrolled in a Medicare Advantage Plan provided by a health maintenance organization (HMO). The HMO made conditional payments on behalf of the injured persons to cover medical expenses in each accident. The HMO assigned its claims under the Medicare Secondary Payer Act (the MSP Act). Click title to continue reading...


FEATURE


Summary Judgment: Breast Reconstruction Malpractice

As a special feature for our Premium subscribers we have included this feature containing an illustrative Motion for Summary Judgment by the defendant physician providing follow-up care in a medical malpractice action involving breast reconstruction after a lumpectomy and radiation. Plaintiff’s injury included nipple tissue necrosis. The defendant’s reconstruction surgery was not alleged to be negligent. Click title to continue reading...